Date:March 24, 2026
Bio Usawa is participating in the Biomanufacturing Regulation & Market Access Forum taking place March 24–25 in Accra.
Dr. Patrick Lukulay, Chief Operating Officer of Bio Usawa, will serve as a panelist on the session "Market Developments 2025–2030: Supply Security and Pooled Procurement of Vaccines and Biological Products in Line with International Regulatory Requirements."
The forum convenes key stakeholders to examine evolving regulatory landscapes, strengthen market access pathways, and advance supply security for vaccines and biological products across Africa.
Bio Usawa’s participation underscores its commitment to the development of resilient, Africa-led biomanufacturing ecosystems and contributing to sustainable solutions for equitable access to essential health technologies.
The AORTIC–Bio Usawa Microgrant Program was launched to support African researchers addressing serious gaps in cancer care systems. Out of more than 150…
April 2026The inaugural AORTIC–Bio Usawa Microgrant Program brings together a cohort of early- and mid-career researchers, each addressing critical gaps in cancer…
April 2026The AORTIC—Bio Usawa Microgrant Program is supporting a cohort of five early-career researchers advancing practical solutions in cancer care. The group …
April 2026